Healthcare -
Biotechnology - NASDAQ - US
$ 1.28
1.59 %
$ 76.9 M
Market Cap
-0.93
P/E
Price Target
Average
446.88%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.79%
Net Income
Estimate
--19.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Acumen Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ABOS of $7 , with forecasts ranging from
a
low of
$7 to a high of $7 .
ABOS Lowest Price Target
Wall Street Target
7 USD
446.88%
ABOS Average Price Target
Wall Street Target
7 USD
446.88%
ABOS Highest Price Target
Wall Street Target
7 USD
446.88%
REVENUE FORECAST
Revenue Forecast Chart ABOS
EBIT FORECAST
EBIT Forecast Chart ABOS
NET INCOME FORECAST
Net Income Chart ABOS